Cargando…
Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation – Authors' reply
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990474/ https://www.ncbi.nlm.nih.gov/pubmed/33782670 http://dx.doi.org/10.1016/S2665-9913(21)00066-7 |
| _version_ | 1783669080778080256 |
|---|---|
| author | Cavalli, Giulio Larcher, Alessandro Tomelleri, Alessandro Dagna, Lorenzo |
| author_facet | Cavalli, Giulio Larcher, Alessandro Tomelleri, Alessandro Dagna, Lorenzo |
| author_sort | Cavalli, Giulio |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7990474 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79904742021-03-25 Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation – Authors' reply Cavalli, Giulio Larcher, Alessandro Tomelleri, Alessandro Dagna, Lorenzo Lancet Rheumatol Correspondence Elsevier Ltd. 2021-04 2021-03-08 /pmc/articles/PMC7990474/ /pubmed/33782670 http://dx.doi.org/10.1016/S2665-9913(21)00066-7 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Cavalli, Giulio Larcher, Alessandro Tomelleri, Alessandro Dagna, Lorenzo Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation – Authors' reply |
| title | Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation – Authors' reply |
| title_full | Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation – Authors' reply |
| title_fullStr | Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation – Authors' reply |
| title_full_unstemmed | Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation – Authors' reply |
| title_short | Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation – Authors' reply |
| title_sort | interleukin-1 and interleukin-6 inhibition in patients with covid-19 and hyperinflammation – authors' reply |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990474/ https://www.ncbi.nlm.nih.gov/pubmed/33782670 http://dx.doi.org/10.1016/S2665-9913(21)00066-7 |
| work_keys_str_mv | AT cavalligiulio interleukin1andinterleukin6inhibitioninpatientswithcovid19andhyperinflammationauthorsreply AT larcheralessandro interleukin1andinterleukin6inhibitioninpatientswithcovid19andhyperinflammationauthorsreply AT tomellerialessandro interleukin1andinterleukin6inhibitioninpatientswithcovid19andhyperinflammationauthorsreply AT dagnalorenzo interleukin1andinterleukin6inhibitioninpatientswithcovid19andhyperinflammationauthorsreply |